Mathes Company’s iShares Biotechnology ETF IBB Stock Holding History

Mathes Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,765	Closed	-$791K	–	131
2024 Q1	$791K	Hold	5,765	–	–	0.3%	71
2023 Q4	$783K	Hold	5,765	–	–	0.32%	66
2023 Q3	$705K	Hold	5,765	–	–	0.33%	68
2023 Q2	$732K	Buy	+5,765	New	+$732K	0.32%	68
2022 Q4	$758K	Hold	5,775	–	–	0.38%	66
2022 Q3	$675K	Hold	5,775	–	–	0.38%	71
2022 Q2	$679K	Hold	5,775	–	–	0.33%	79
2022 Q1	$752K	Hold	5,775	–	–	0.29%	78
2021 Q4	$881K	Hold	5,775	–	–	0.3%	76
2021 Q3	$934K	Hold	5,775	–	–	0.35%	73
2021 Q2	$945K	Hold	5,775	–	–	0.34%	72
2021 Q1	$869K	Hold	5,775	–	–	0.34%	73
2020 Q4	$875K	Hold	5,775	–	–	0.36%	71
2020 Q3	$782K	Hold	5,775	–	–	0.36%	70
2020 Q2	$789K	Sell	5,775 -665	-10%	-$90.9K	0.39%	68
2020 Q1	$694K	Hold	6,440	–	–	0.46%	61
2019 Q4	$776K	Sell	6,440 -75	-1%	-$9.04K	0.36%	70
2019 Q3	$648K	Sell	6,515 -3,700	-36%	-$368K	0.33%	76
2019 Q2	$1.11M	Sell	10,215 -100	-1%	-$10.9K	0.59%	51
2019 Q1	$1.15M	Sell	10,315 -570	-5%	-$63.7K	0.59%	55
2018 Q4	$1.05M	Sell	10,885 -635	-6%	-$61.3K	0.66%	51
2018 Q3	$1.41M	Sell	11,520 -600	-5%	-$73.2K	0.66%	49
2018 Q2	$1.33M	Sell	12,120 -1,200	-9%	-$132K	0.63%	50
2018 Q1	$1.42M	Sell	13,320 -285	-2%	-$30.4K	0.66%	46
2017 Q4	$1.45M	Sell	13,605 -450	-3%	-$48.1K	0.66%	47
2017 Q3	$1.56M	Buy	14,055 +3,180	+29%	+$354K	0.74%	45
2017 Q2	$1.12M	Buy	10,875 +1,500	+16%	+$155K	0.54%	52
2017 Q1	$916K	Buy	9,375 +1,065	+13%	+$104K	0.49%	56
2016 Q4	$735K	Buy	8,310 +1,410	+20%	+$125K	0.4%	63
2016 Q3	$666K	Buy	6,900 +900	+15%	+$86.9K	0.38%	66
2016 Q2	$515K	Buy	6,000 +780	+15%	+$67K	0.3%	78
2016 Q1	$454K	Buy	5,220 +900	+21%	+$78.3K	0.27%	85
2015 Q4	$487K	Buy	4,320 +1,185	+38%	+$134K	0.28%	86
2015 Q3	$317K	Buy	3,135 +1,170	+60%	+$118K	0.21%	99
2015 Q2	$242K	Buy	+1,965	New	+$242K	0.13%	135